Home » Medtech a ‘Bright Spot’ in Q3 Lifesciences Investment, Analysts Say
Medtech a ‘Bright Spot’ in Q3 Lifesciences Investment, Analysts Say
There has been much recent hand-wringing about the lack of availability of funding for medtech startups, but analysts at PricewaterhouseCoopers see it a little differently.
MassDevice
MassDevice
Upcoming Events
-
07May
-
14May
-
30May